Ma X - Search Results

1

Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis.

Wu S, Ma X, Zhang X, Du K, Shi C, Almaamari AA, Han B, Su S, Liu Y. Wu S, et al. Among authors: ma x. Cancer Biol Ther. 2025 Dec;26(1):2445220. doi: 10.1080/15384047.2024.2445220. Epub 2024 Dec 20. Cancer Biol Ther. 2025. PMID: 39706687 Free article.

2

Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study.

Du KY, Wu S, Ma X, Liu Y. Du KY, et al. Among authors: ma x. Breast Cancer Res Treat. 2024 Oct;207(3):517-527. doi: 10.1007/s10549-024-07430-7. Epub 2024 Jul 11. Breast Cancer Res Treat. 2024. PMID: 38990453

3

The expression landscape of FOXP3 and its prognostic value in breast cancer.

Li J, Zhang X, Liu B, Shi C, Ma X, Ren S, Zhao X, Liu Y. Li J, et al. Among authors: ma x. Ann Transl Med. 2022 Jul;10(14):801. doi: 10.21037/atm-22-3080. Ann Transl Med. 2022. PMID: 35965804 Free PMC article.

4

Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis.

Zhang W, Wu S, Liu J, Zhang X, Ma X, Yang C, Cao M, Zhang S, Liu Y. Zhang W, et al. Among authors: ma x. Front Oncol. 2022 Oct 13;12:872862. doi: 10.3389/fonc.2022.872862. eCollection 2022. Front Oncol. 2022. PMID: 36313697 Free PMC article.

5

Survival outcomes of autologous breast reconstruction after mastectomy: A matched case-control study.

Wu S, Ma X, Zhang X, Yang C, Wang Y, Liu Y. Wu S, et al. Among authors: ma x. Front Oncol. 2023 Jan 6;12:1022925. doi: 10.3389/fonc.2022.1022925. eCollection 2022. Front Oncol. 2023. PMID: 36686843 Free PMC article.

6

PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity.

Du R, Zhang X, Lu X, Ma X, Guo X, Shi C, Ren X, Ma X, He Y, Gao Y, Liu Y. Du R, et al. Among authors: ma x. Drug Resist Updat. 2023 May;68:100947. doi: 10.1016/j.drup.2023.100947. Epub 2023 Feb 9. Drug Resist Updat. 2023. PMID: 36812747

7

Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway.

Chen NN, Ma XD, Miao Z, Zhang XM, Han BY, Almaamari AA, Huang JM, Chen XY, Liu YJ, Su SW. Chen NN, et al. Front Pharmacol. 2023 Jul 19;14:1150861. doi: 10.3389/fphar.2023.1150861. eCollection 2023. Front Pharmacol. 2023. PMID: 37538178 Free PMC article.

8

Relationship between oily fish intake and breast cancer based on estrogen receptor status: a Mendelian randomization study.

Wu S, Ma X, Zhang X, Shi C, Cao M, Yang C, Qi Y, Liu Y. Wu S, et al. Among authors: ma x. Breast Cancer Res Treat. 2024 Jan;203(1):145-152. doi: 10.1007/s10549-023-07130-8. Epub 2023 Oct 3. Breast Cancer Res Treat. 2024. PMID: 37787818

9

Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2- breast cancer: a propensity score-matched retrospective cohort study using the SEER database.

Ma X, Wu S, Zhang X, Chen N, Yang C, Yang C, Cao M, Du K, Liu Y. Ma X, et al. BMJ Open. 2024 Mar 15;14(3):e078782. doi: 10.1136/bmjopen-2023-078782. BMJ Open. 2024. PMID: 38490656 Free PMC article.

10

Genetic evidence supporting the causal role of 25-hydroxyvitamin D levels in the prognosis of ER- breast cancer: A Mendelian randomization study.

Wu S, Ma XD, Zhang XM, Shi C, Du KY, Liu YJ. Wu S, et al. Medicine (Baltimore). 2024 Oct 25;103(43):e40262. doi: 10.1097/MD.0000000000040262. Medicine (Baltimore). 2024. PMID: 39470482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,578 results

Search Page

Filters